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The repercussions of infection by the new coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
pregnant women and newborns are still not well known,
with little scientific evidence about their manifestation in
the mother-child binomial. Vertical transmission seems
possible but has not been documented (1,2). Furthermore,
the virus has not been detected in human milk, enabling
breastfeeding with protection or the use of expressed milk
from the mother (1-3).
Several studies (1,3-7) published to date suggest the pos-
sibility of vertical transmission of SARS-CoV-2, but none of
them have confirmed this. The virus was not found in amni-
otic fluid, placenta, umbilical cord blood, and breast milk
samples.
Existing data suggest that neonatal transmission of SARS-
CoV-2 occurs mainly through droplets from infected caregivers
or through contact with contaminated biological material.
There are clinical case reports that describe late infection in
newborns of mothers infected with SARS-CoV-2. Most of
these children presented with mild signs and symptoms, but
some developed sepsis and severe respiratory failure (8-10).
We present a case that is similar to most reports in the
literature published until now: the patient was a male infant
of a 37-year-old mother, with a gestational age of 39 5/7
weeks and no prenatal complications. He was born vaginally,
with Apgar scores of 8 and 9 (1st and 5th minute), weight
3.050g, length 51 cm, and head circumference 35 cm. The
mother’s amniotic membranes had ruptured 11 hours before
delivery.
The patient presented with early respiratory distress,
which improved after receiving inhaled oxygen in the first
12 hours of life. Blood was collected to examine for early
neonatal sepsis; the results of the examination were normal.
Chest radiography showed a left clavicle fracture without
pulmonary involvement. The patient was discharged home
on the third day of life, on exclusive breastfeeding. His family
members complied with the isolation requirements recom-
mended by the Ministry of Health of Brazil (7), and they were
asymptomatic. This newborn had had no contact with other
patients who had flu-like syndrome.
At 11 days of age, the newborn had two episodes of
hyperthermia and mild respiratory distress, according to the
mother’s report. On examination, the blood count, blood
culture results, serum C-reactive protein levels, liquor levels,
and type 1 urine examination results were normal. Chest
radiography did not reveal any changes in the lung fields.
Assessment of nasal and oropharyngeal samples for SARS-
CoV-2 by reverse transcription followed by polymerase chain
reaction (RT-PCR) revealed positive results.
At age 13 days, the infant was transferred to the Neonatal
Center of Instituto da Criança, Hospital das Clínicas, Faculty
of Medicine-University of São Paulo, and did not show any
respiratory symptoms in room air. He remained in room air
throughout hospitalization. He had a hemoglobin saturation
greater than 94%, was afebrile, and had a normal heart rate.
Pulmonary ultrasonography showed changes compatible
with bilateral interstitial involvement (Figure 1). He was
mostly breastfed, and was given formula only when breast
milk was unavailable.
The spectrum of clinical manifestations of SARS-CoV-2
infection in newborns is still under study. Until now, the
presence of the virus in biological materials has not been
sufficient to prove its vertical transmission (1,3,6). Case reports
have indicated postnatal acquisition of coronavirus disease
(COVID-19), as in the case described. The patient’s mother did
not present respiratory symptoms or show any other clinical
evidence of illness. The only finding was rupture of amniotic
membranes 11 hours before delivery. The newborn developed
early and transient respiratory distress without other compli-
cations. Respiratory distress in the neonatal period among
neonates with COVID-19-positive mothers may be related to
the neonates innate conditions and should not always be
attributed to SARS-CoV-2 infection (1,3,8,9).
The patient remained in the exclusive breastfeeding room
until discharge home on the third day of life. The binomial
was discharged home, where all residents followed social
isolation advocated by the state government and did not
present any signs or symptoms of COVID-19.
Horizontal transmission seems to be the most likely route
of SARS-CoV-2 infection in this case, perhaps through
contact with an asymptomatic carrier of the virus.
In the studies (1,3,5,6) conducted until now, the human
milk samples tested were negative for the presence of the
virus, which made it possible to continue breastfeeding evenDOI: 10.6061/clinics/2020/e1996
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in symptomatic women. In such cases, it is necessary that the
rules of home isolation be respected, suggesting participation
of healthy family members in providing care to the newborn
during the period of maternal convalescence. The use of a
surgical mask, frequent hand hygiene, and observation for
warning signs that the newborn may present with are
recommended.
The clinical manifestation of COVID-19 among children
is characterized by fever, dry cough, tiredness, and a runny
nose. Some patients have manifestations in the digestive
tract, such as bloating, nausea, vomiting, diarrhea, and
abdominal pain. Some cases may present with skin rashes.
The progression is generally benign, with complete resolu-
tion of the condition within two weeks after symptom onset
(11,12).
Descriptions of clinical manifestations in neonates are
rarer. A case of severe late-onset neonatal sepsis was recently
reported at the University of Texas, with the newborn
needing orotracheal intubation and vasoactive drug admin-
istration (11).
Much attention is needed at this stage because, to date, the
most severe respiratory distress syndromes appear concomi-
tantly with other conditions characteristic of the neonatal
period. One should always conduct assessments on a case-
by-case basis, classify respiratory failure, and prescribe the
best treatment for the patient.
According to Hong et al., (12) the criteria for the diagnosis
of COVID-19 among neonates are as follows: thermal
instability, hypoactivity, difficulty in feeding, or respiratory
distress; alterations of chest radiographs with a single or
bilateral ground-glass pattern; diagnosis of COVID-19 in a
relative or caregiver of the newborn; and intimate contact
with people confirmed or suspected of having COVID-19 or
with patients with unexplained pneumonia.
Our patient fulfilled only two the criteria: temperature
instability and mild respiratory distress. His hemoglobin
saturation at admission was 91% in room air. The tests
collected initially did not show any hematological changes,
such as leukocytosis or leukopenia, and the platelet count
was normal. His serum C-reactive protein level was normal.
Because of the presence of fever, urine and cerebrospinal
fluid samples were tested, and meningitis and urinary tract
infection were ruled out. Ampicillin, cefotaxime, and osel-
tamivir were administered. The neonate tested positive for
COVID-19 24 hours after admission and was transferred to a
Neonatal Intensive Care Unit for patients with COVID-19
during the pandemic. The blood samples collected at
hospital admission did not show bacterial growth, and the
administration of antibiotics was suspended after 48 hours.
The newborn was hospitalized for seven days. He remained
asymptomatic throughout the hospitalization, with oxygen
saturation above 94% and a temperature between 36.5 and
37oC. Disease progression was good, as in other cases (9,10)
described in the literature.
COVID-19 has a highly variable clinical presentation, and
there are still few case reports on COVID-19 in the neonatal
period. Many neonates present with symptoms and signs
that overlap with those of diseases typical of this age range.
The biggest challenge is to recognize the characteristics
of COVID-19 among other manifestations of neonatal dis-
eases and to choose the most appropriate treatment for the
patients.
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